RXI PHARMACEUTICALS CORP (RXII) has 70 open-market insider trades by 13 insiders since 2009. The most active filer is Geert Cauwenbergh, President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Corp Cytrx | 10% | — | 4 | $11.5M | 2010-12-29 |
| Biopharma Inc. Galena | 10% | — | 1 | $209K | 2013-05-02 |
| Geert Cauwenbergh | Pres | — | 53 | $205K | 2018-11-09 |
| Sanford Hillsberg | Dir | — | 1 | $142K | 2011-04-13 |
| Stephen S. Galliker | Dir | — | 1 | $83K | 2010-03-26 |
| Noah D. Beerman | Pres | — | 1 | $22K | 2011-03-15 |
| Dmitry Samarsky | VPTechnology Development | — | 1 | $19K | 2010-03-31 |
| Robert J. Bitterman | Dir | — | 3 | $12K | 2018-08-01 |
| Ramani Varanasi | VP Business Development | — | 1 | $10K | 2011-03-15 |
| Mark J. Ahn | Pres | — | 1 | $10K | 2011-04-20 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Geert Cauwenbergh | President | Buy | $4K | 2017-10-02 |
| Alexey Eliseev | Chief Business Officer | Sell | $95K | 2017-09-05 |
| Alexey Eliseev | Chief Business Officer | Sell | $13K | 2017-09-01 |
| Geert Cauwenbergh | President | Buy | $6K | 2017-08-24 |
| Gerrit Dispersyn | Chief Development Officer | Buy | $2K | 2017-06-23 |
| Geert Cauwenbergh | President | Buy | $6K |
Companies that share insiders with RXII, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2017-06-22 |
| Geert Cauwenbergh | President | Buy | $7K | 2017-04-26 |
| Geert Cauwenbergh | President | Buy | $8K | 2017-03-17 |
| Geert Cauwenbergh | President | Buy | $7K | 2017-02-17 |
| Geert Cauwenbergh | President | Buy | $7K | 2017-02-08 |
| Geert Cauwenbergh | President | Buy | $7K | 2017-01-25 |
| Geert Cauwenbergh | President | Buy | $7K | 2017-01-19 |
| Geert Cauwenbergh | President | Buy | $4K | 2015-04-02 |
| Geert Cauwenbergh | President | Buy | $5K | 2015-02-17 |
| Geert Cauwenbergh | President | Buy | $2K | 2015-02-10 |